Dyne Therapeutics, Inc. DYN Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s other operating expenses?
- Dyne Therapeutics, Inc. (DYN) reported other operating expenses of $125.28M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Dyne Therapeutics, Inc.'s other operating expenses increased by 2.4% year-over-year, from $122.37M to $125.28M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s other operating expenses has grown at a 32.9% compound annual growth rate (CAGR), from $150.03M to $468.18M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.